Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,136 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Restenosis--an open file.
Gottsauner-Wolf M, Moliterno DJ, Lincoff AM, Topol EJ. Gottsauner-Wolf M, et al. Clin Cardiol. 1996 May;19(5):347-56. doi: 10.1002/clc.4960190505. Clin Cardiol. 1996. PMID: 8723592 Review.
The early history and development of thrombolysis in acute myocardial infarction.
Maroo A, Topol EJ. Maroo A, et al. J Thromb Haemost. 2004 Nov;2(11):1867-70. doi: 10.1111/j.1538-7836.2004.00881.x. J Thromb Haemost. 2004. PMID: 15550011 No abstract available.
Acute myocardial infarction: thrombolysis.
Topol EJ. Topol EJ. Heart. 2000 Jan;83(1):122-6. doi: 10.1136/heart.83.1.122. Heart. 2000. PMID: 10618353 Free PMC article. Review. No abstract available.
Comparison of the ABC/2 estimation technique to computer-assisted volumetric analysis of intraparenchymal and subdural hematomas complicating the GUSTO-1 trial.
Gebel JM, Sila CA, Sloan MA, Granger CB, Weisenberger JP, Green CL, Topol EJ, Mahaffey KW. Gebel JM, et al. Stroke. 1998 Sep;29(9):1799-801. doi: 10.1161/01.str.29.9.1799. Stroke. 1998. PMID: 9731597
Benefit of early sustained reperfusion in patients with prior myocardial infarction (the GUSTO-I trial). Global Utilization of Streptokinase and TPA for occluded arteries.
Brieger DB, Mak KH, White HD, Kleiman NS, Miller DP, Vahanian A, Ross AM, Califf RM, Topol EJ. Brieger DB, et al. Am J Cardiol. 1998 Feb 1;81(3):282-7. doi: 10.1016/s0002-9149(97)00909-0. Am J Cardiol. 1998. PMID: 9468068
Glycoprotein IIb/IIIa antagonists--from bench to practice.
Casserly IP, Topol EJ. Casserly IP, et al. Cell Mol Life Sci. 2002 Mar;59(3):478-500. doi: 10.1007/s00018-002-8440-8. Cell Mol Life Sci. 2002. PMID: 11964126 Review.
Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization.
Topol EJ, Moliterno DJ, Herrmann HC, Powers ER, Grines CL, Cohen DJ, Cohen EA, Bertrand M, Neumann FJ, Stone GW, DiBattiste PM, Demopoulos L; TARGET Investigators. Do Tirofiban and ReoPro Give Similar Efficacy Trial. Topol EJ, et al. N Engl J Med. 2001 Jun 21;344(25):1888-94. doi: 10.1056/NEJM200106213442502. N Engl J Med. 2001. PMID: 11419425 Clinical Trial.
1,136 results
Jump to page
Feedback